Suppression-subtractive hybridisation reveals variations in gene distribution amongst the Burkholderia cepacia complex, including the presence in some strains of a genomic island containing putative polysaccharide production genes

Archives of Microbiology

Volumn 179, Issue 3, 2003, Pages 214-223

  Parsons, Yasmin N ^a   Banasko, Rebecca ^a   Detsika, Maria G ^a   Duangsonk, Kwanjit ^a   Rainbow, Lucille ^a   Hart, C Anthony ^a   Winstanley, Craig ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Burkholderia cepacia; Capsule; Cystic fibrosis; Subtraction hybridisation

Indexed keywords

POLYSACCHARIDE;

ARTICLE; BACTERIAL STRAIN; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; DNA HYBRIDIZATION; GENE CLUSTER; GENE EXPRESSION; GENE MAPPING; GENE REPRESSION; GENE SEQUENCE; GENE TRANSFER; GENETIC VARIABILITY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA AMBIFARIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA MALLEI; BURKHOLDERIA MULTIVORANS; BURKHOLDERIA STABILIS; BURKHOLDERIA VIETNAMENSIS; BURKHOLDERIA VIETNAMIENSIS; NEGIBACTERIA; PROKARYOTA;

EID: 0037333188     PISSN: 03028933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00203-003-0518-7     Document Type: Article

References (34)

1. Agodi A, Mahenthiralingam E, Barchitta M, Giannino V, Sciacca A, Stefani S (2001) Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol 39:2891-2896
2. Agron PG, Macht M, Radnedge L, Skowronski EW, Miller W, Andersen GL (2002) Use of subtractive hybridization for comprehensive surveys of prokaryotic genome differences. FEMS Microbiol Lett 211:175-182
3. Cérantola S, Montrozier H (2001) Production in vitro, on different solid culture media, of two distinct exopolysaccharides by a mucoid clinical strain of Burkholderia cepacia. FEMS Microbiol Lett 202:129-133
4. Cérantola S, Marty N, Montrozier H (1996) Structural studies of the acidic exopolysaccharide produced by a mucoid strain of Burkholderia cepacia, isolated from cystic fibrosis. Carbohydr Res 285:59-67
5. Cérantola S, Lemassu-Jacquier A, Montrozier H (1999) Structural elucidation of a novel exopolysaccharide produced by a mucoid clinical isolate of Burkholderia cepacia. Characterization of a trisubstituted glucuronic acid residue in a heptasaccharide repeating unit. Eur J Biochem 260:373-383
6. Cérantola S, Bounery J, Segonds C, Marty N, Montrozier H (2000) Exopolysaccharide production by mucoid and non-mucoid strains of Burkholderia cepacia. FEMS Microbiol Lett 185:243-246
7. Cieri MV, Mayer-Hamblett N, Griffith A, Burns JL (2002) Correlation between an in vitro invasion assay and a murine model of Burkholderia cepacia lung infection. Infect Immun 70:1081-1086
8. Coenye T, Vandamme P, Govan JR, LiPuma JJ (2001) Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol 39:3427-3436
9. DeShazer D, Waag DM, Fritz DL, Woods DE (2001) Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb Pathog 30:253-269
10. Frosch M, Edwards U, Bousset K, Krausse B, Weisgerber C (1991) Evidence for a common molecular origin of the capsule gene loci in gram- negative bacteria expressing group II capsular polysaccharides. Mol Microbiol 5:1251-1263
11. Glass S, Govan JR (1986) Pseudomonas cepacia - fatal pulmonary infection in a patient with cystic fibrosis. J Infect 13:157-158
12. Gonzalez CF, Pettit EA, Valadez VA, Provin EM (1997) Mobilization, cloning, and sequence determination of a plasmid-encoded polygalacturonase from a phytopathogenic Burkholderia (Pseudomonas) cepacia. Mol Plant Microbe Interact 10:840-851
13. Govan JR, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, Greening AP, Webb AK (1993) Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19
14. Hacker J, Kaper JB (2000) Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol 54:641-679
15. Hentschel U, Hacker J (2001) Pathogenicity islands: the tip of the iceberg. Microbes Infect 3:545-548
16. Johnson WM, Tyler SD, Rozee KR (1994) Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol 32:924-930
17. Lagatolla C, Skerlavaj S, Dolzani L, Tonin EA, Monti-Bragadin C, Bosco M, Rizzo R, Giglio L, Cescutti P (2002) Microbiological characterisation of Burkholderia cepacia isolates from cystic fibrosis patients: investigation of the exopolysaccharides produced. FEMS Microbiol Lett 209:99-106
18. LiPuma JJ, Spilker T, Gill LH, Campbell PW, III, Liu L, Mahenthiralingam E (2001) Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 164:92-96
19. Lo RY, McKerral LJ, Hills TL, Kostrzynska M (2001) Analysis of the capsule biosynthetic locus of Mannheimia (Pasteurella) haemolytica A1 and proposal of a nomenclature system. Infect Immun 69:4458-4464
20. Mahenthiralingam E, Simpson DA, Speert DP (1997) Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol 35:808-816
21. Mahenthiralingam E, Coenye T, Chung JW, Speert DP, Govan JR, Taylor P, Vandamme P (2000a) Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol 38:910-913
22. Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, Vandamme P (2000b) DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 38:3165-3173
23. Mahenthiralingam E, Baldwin A, Vandamme P (2002) Burkholderia cepacia complex infection in patients with cystic fibrosis. J Med Microbiol 51:533-538
24. Millar-Jones L, Ryley HC, Paull A, Goodchild MC (1998) Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients. Respir Med 92:178-183
25. Reckseidler SL, DeShazer D, Sokol PA, Woods DE (2001) Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomatlei as a major virulence determinant. Infect Immun 69:34-44
26. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA, Barrell B (2000) Artemis: sequence visualisation and annotation. Bioinformatics 16:944-945
27. Sajjan US, Sun L, Goldstein R, Forstner JF (1995) Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol 177:1030-1038
28. Sajjan U, Wu Y, Kent G, Forstner J (2000) Preferential adherence of cable-piliated Burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants. J Med Microbiol 49:875-885
29. Sajjan U, Ackerley C, Forstner J (2002) Interaction of cblA/adhesin-positive Burkholderia cepacia with squamous epithelium. Cell Microbiol 4:73-86
30. Schwab U, Leigh M, Ribeiro C, Yankaskas J, Burns K, Gilligan P, Sokol P, Boucher R (2002) Patterns of epithelial cell invasion by different species of the Burkholderia cepacia complex in well-differentiated human airway epithelia. Infect Immun 70:4547-4555
31. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E (2002) Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis in Canada. Emerg Infect Dis 8:181-187.
32. Winstanley C (2002) Spot the difference: applications of subtractive hybridisation to the study of bacterial pathogens. J Med Microbiol 51:459-467
33. - phenotypes. J Clin Microbiol 38:883-885
34. Winstanley C, Hart CA (2001) Type III secretion systems and pathogenicity islands. J Med Microbiol 50:116-126